In a recent study, one rare coding variant in the BTNL2 gene within the Major histocompatibility complex (MHC) region was associated with higher IBD risk (OR-2.3), giving an insight into T cell activation mechanisms and IBD sub-phenotype developments (18). The gene discussed is BTNL2; the disease is irritable bowel syndrome.